Showing results (831-840 of 3,789) with videos related to
Sort By:
Pageof 379
Oncoimmunology|July 30, 2024
Selective lysis of acute myeloid leukemia cells by CD34/CD3 bispecific antibody through the activation of γδ T-cellsFaisal Al Agrafi, Ahmed Gaballa, Paula Hahn, et al.Oncoimmunology|July 29, 2024
S100A10 promotes cancer metastasis via recruitment of MDSCs within the lungsJuan Li, Can Zhou, Xiaoqian Gao, et al.Oncoimmunology|July 3, 2024
Faecalibaterium prausnitzii strain EXL01 boosts efficacy of immune checkpoint inhibitorsMarius Bredon, Camille Danne, Hang Phuong Pham, et al.Oncoimmunology|August 27, 2024
Local therapy with combination TLR agonists stimulates systemic anti-tumor immunity and sensitizes tumors to immune checkpoint blockadeFrancois Xavier Rwandamuriye, Tao Wang, Hanfu Zhang, et al.Oncoimmunology|August 13, 2024
Transcriptomics-based characterization of the immuno-stromal microenvironment in pediatric low-grade gliomaMeik Körner, Michael Spohn, Ulrich Schüller, et al.Oncoimmunology|June 26, 2024
A phase 2 study of spartalizumab (PDR001) among patients with recurrent or metastatic esophageal squamous cell carcinoma (KCSG HN18-17, K-MASTER project 12)Dong Ki Lee, Sook Ryun Park, Yeul Hong Kim, et al.Oncoimmunology|April 30, 2024
Immune checkpoint therapy responders display early clonal expansion of tumor infiltrating lymphocytesJoel Kidman, Rachael M Zemek, John-William Sidhom, et al.Oncoimmunology|June 7, 2024
β-Lapachone promotes the recruitment and polarization of tumor-associated neutrophils (TANs) toward an antitumor (N1) phenotype in NQO1-positive cancersSoumya Tumbath, Lingxiang Jiang, Xiaoguang Li, et al.Oncoimmunology|May 15, 2024
Characterization of innate lymphoid cell subsets infiltrating melanoma and epithelial ovarian tumorsDouglas C Chung, Maryam Ghaedi, Kathrin Warner, et al.Oncoimmunology|April 25, 2024
The potential role of CMC1 as an immunometabolic checkpoint in T cell immunityYuwen Chen, Jie Gao, Mingyue Ma, et al.Pageof 379